Concizumab dose escalation by hemophilia type
| . | HA . | HAwI . | HBwI . |
|---|---|---|---|
| N | 36 | 9 | 8 |
| Dose escalation, n (%) | |||
| None: 0.15 mg/kg only | 21 (58.3) | 8 (88.9) | 7 (87.5) |
| One: 0.15 and 0.20 mg/kg | 7 (19.4) | 1 (11.1) | 1 (12.5) |
| Two: 0.15, 0.20, and 0.25 mg/kg | 8 (22.2) | 0 (0.0) | 0 (0.0) |
| . | HA . | HAwI . | HBwI . |
|---|---|---|---|
| N | 36 | 9 | 8 |
| Dose escalation, n (%) | |||
| None: 0.15 mg/kg only | 21 (58.3) | 8 (88.9) | 7 (87.5) |
| One: 0.15 and 0.20 mg/kg | 7 (19.4) | 1 (11.1) | 1 (12.5) |
| Two: 0.15, 0.20, and 0.25 mg/kg | 8 (22.2) | 0 (0.0) | 0 (0.0) |
Concizumab dose escalation by hemophilia type in explorer4 (HAwI/HBwI) and explorer5 (HAwI) (concizumab-treated patients only; full analysis set).